Standex International Reports Fiscal Q4 and FY2026 Results: Key Highlights for Investors
Introduction
Standex International Corporation (NYSE: SXI) has released its financial results for the fourth quarter and fiscal year ended June 30, 2026. This report contains several key developments and financial results that may be of significant interest to shareholders and could impact the company’s share price.
Key Financial Highlights
- Organic Growth: The company reported strong organic growth of 7.7% in Q4, with the Electronics segment leading at 12.9% organic growth.
- New Product Sales: Sales from new products grew by 43% year-over-year. Sales into fast-growth markets contributed 31% of total sales, amounting to ~\$72 million in Q4 and ~\$264 million for the year.
- Record Order Intake: Standex achieved record order intake of approximately \$270 million with a book-to-bill ratio of 1.18. The Electronics book-to-bill ratio was even higher at 1.27.
- EPS Performance: Q4 FY26 GAAP EPS was \$1.69, while adjusted EPS hit a record \$2.45 (up 7.4% year-over-year).
- Operating Income: Q4 GAAP operating income was \$45.4 million (adjusted), while GAAP operating income was \$44.2 million.
- Free Cash Flow: Q4 free cash flow was \$35.0 million.
- Net Leverage: The company’s net leverage ratio fell to 1.8x.
- Dividend Increase: Standex increased its quarterly dividend by 6.3% to \$0.34 per share, payable August 21, 2026, to shareholders of record on August 7, 2026.
- Share Repurchase: No shares were repurchased during the quarter. Approximately \$28 million remains under the current repurchase authorization.
- Interest Expense Guidance: For Q1 FY2027, expected interest expense is approximately \$7.0 million.
- Capital Expenditures: Q4 capital expenditures were not specified but are mentioned as ongoing.
Segment Performance Detail
Electronics Segment
- Revenue: \$129.1 million (up from \$115.2 million YOY; +12.1%)
- GAAP Operating Income: \$31.6 million (versus \$28.0 million YOY)
- GAAP Operating Margin: 24.5%
- Adjusted Operating Income: \$35.1 million
- Organic growth was a key driver of company outperformance.
Scientific Segment
- Revenue: \$18.8 million (up from \$17.9 million YOY; +5.0%)
- GAAP Operating Income: \$5.2 million
- GAAP Operating Margin: 27.7%
- Adjusted Operating Income: \$5.4 million
Other Segments
- Some segments saw revenue declines, e.g., one segment reported a 9.7% YOY revenue decrease, reflecting general market weakness.
- Adjusted operating income in this segment was down 8.5% YOY.
Operational and Strategic Developments
- Executive Change: On July 30, 2026, Alan J. Glass, Vice President, Chief Legal Officer & Secretary, departed the company. This is noteworthy from a governance and continuity perspective and may attract investor attention.
- Forward Guidance: For Q1 FY2027, Standex expects slightly to moderately higher revenue and similar or slightly higher adjusted operating margin compared to Q4 2026.
Forward-Looking Statements and Risks
Standex’s management emphasizes that forward-looking statements are subject to risks, including macroeconomic conditions, supply chain disruptions, foreign currency fluctuations, and the potential impact of new acquisitions and cybersecurity threats. Investors should reference the company’s latest 10-K and risk factor disclosures for a comprehensive view of risks.
Key Takeaways for Shareholders
- Strong Q4 results, above-average organic growth, and record adjusted EPS are likely to be viewed positively by the market.
- Dividend increase and reduced leverage strengthen the company’s commitment to shareholder returns and balance sheet management.
- No share repurchases in Q4 may prompt questions about capital allocation, but authorization remains in place.
- Executive leadership change could be a point of concern or scrutiny.
- Forward guidance remains cautiously optimistic, suggesting stable or improving conditions into FY2027.
Contact
- Christopher Howe, Director of Investor Relations
- Phone: (773) 754-5394
- Email: Not provided
Disclaimer:
This article is for informational purposes only and does not constitute investment advice. Forward-looking statements are based on current management expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Investors should consult official company filings and their financial advisors before making investment decisions.
